Olena Brovko

Analist at Viroclinics Biosciences BV
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
The Randstad, Netherlands, NL

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
You need to have a working account to view this content.

Experience

    • Netherlands
    • Biotechnology Research
    • 200 - 300 Employee
    • Analist
      • Jun 2020 - Present

    • Education Administration Programs
    • 700 & Above Employee
    • Scientific co-worker, MD
      • Nov 2012 - Mar 2013

      Confirmed a highly protective effect of the large surface protein in prophylactic immunization against hepatitis B virus (HBV)-related woodchuck hepatitis virus (WHV) in a woodchuck model.• Established new and efficient in vitro neutralization assay using the primary woodchuck hepatocytes (PWH). Proved the high neutralization potential of antibodies produced against WHV large surface protein in the established assay.• Identified the most important sequence within WHV large surface protein which elicits antibody response associated with protection against WHV infection. Show less

    • MD student
      • Jul 2009 - Nov 2012

      • Created a new strategy for the improvement of HBV prophylactic and therapeutic vaccines’ immunogenicity: the combination of highly immunogenic non-infectious HBV core protein (HBcAg) capsid-like particles as carriers and immunogenicity enhancers for the neutralizing epitopes of the large HBV surface protein participating in binding to hepatocytes.• Proved the potency of HBcAg to induce a vigorous T- and B-cell immune responses and its ability to ensure a high level of B-cell immunogenicity to the fused surface protein’s sequence. Show less

    • Research associate
      • Aug 2004 - Jul 2009

      Demonstrated the ability of the new immune biological preparation named Human Cord Blood Leuco-concentrate (HCBL) to provide the complete protection of the vaccinated animals upon high-dose influenza virus challenge as well as insusceptibility to influenza viral infection within a year in humans. • Confirmed the contribution of HCBL to the development of powerful antiviral immunity by stimulation of functional activity of monocytes and macrophages and the ability to promote the production of high titers of specific antiviral antibodies. Show less

Education

  • University Duisburg-Essen
    Doctor of Medicine (MD), Virology/Immunology
    2009 - 2012
  • DFG Research Training Group, GRK 1045/2 ”Modulation of host cell functions as a new approach to treating viral and bacterial infections”
    Participant
    2009 - 2012
  • Kharkiv Medical Academy of Advanced Studies
    Diploma, Specialization courses on bacteriology
    2009 -
  • Kharkiv Medical Academy of Advanced Studies
    Diploma, Internship and specialization courses on microbiology and virology
    2003 - 2004
  • Kharkiv National Medical University (Ukraine), Medical and prophylaxis business Faculty
    Honours Diploma, Medical and prophylaxis business
    1997 - 2003
  • Kharkiv State University Lyceum, Ukraine
    Honours Diploma, Chemistry
    1994 - 1997
  • Primary and secondary School Nr. 105, Kharkiv, Ukraine
    1987 - 1994

Community

You need to have a working account to view this content. Click here to join now